All Stories

  1. Neuroprotective Potential of Polydatin in Combating Parkinson’s Disease through the Inhibition of Monoamine Oxidase-B and Catechol-o-Methyl Transferase
  2. Advances in Studies on Stroke-Induced Secondary Neurodegeneration (SND) and Its Treatment
  3. Role of Inflammasomes in Atherosclerosis and Stroke Pathogenesis
  4. Intra-arterial stem cell therapy modulates neuronal calcineurin and confers neuroprotection after ischemic stroke
  5. Therapeutic spectrum of interferon-β in ischemic stroke
  6. Novel Targets for Parkinson’s Disease: Addressing Different Therapeutic Paradigms and Conundrums
  7. A Friend or Foe: Calcineurin across the Gamut of Neurological Disorders
  8. Exposure to hypoglycemia and risk of stroke
  9. Inflammasomes in stroke: a triggering role for acid-sensing ion channels
  10. Nicotine Alters Estrogen Receptor-Beta-Regulated Inflammasome Activity and Exacerbates Ischemic Brain Damage in Female Rats
  11. Noncoding RNAs in ischemic stroke: time to translate
  12. Myeloperoxidase and Neurological Disorder: A Crosstalk
  13. Melatonin protects against behavioral deficits, dopamine loss and oxidative stress in homocysteine model of Parkinson's disease
  14. Mesenchymal Stem Cell Therapy in Ischemic Stroke: A Meta-analysis of Preclinical Studies
  15. Getting Closer to an Effective Intervention of Ischemic Stroke: The Big Promise of Stem Cell
  16. Hypercholesterolemia causes psychomotor abnormalities in mice and alterations in cortico-striatal biogenic amine neurotransmitters: Relevance to Parkinson's disease
  17. Recent Advances in Oncological Submissions of Dendrimer
  18. Diabetic nephropathy: New insights into established therapeutic paradigms and novel molecular targets
  19. Large animal canine endovascular ischemic stroke models: A review
  20. Treatment of unruptured intracranial aneurysms: a review
  21. Resveratrol inhibits matrix metalloproteinases to attenuate neuronal damage in cerebral ischemia: a molecular docking study exploring possible neuroprotection
  22. Piroxicam-mediated modulatory action of 5-hydroxytryptamine serves as a "brake" on neuronal excitability in ischemic stroke
  23. Intra-arterial Approaches to Stem Cell Therapy for Ischemic Stroke
  24. Inhibition of matrix metalloproteinase-2 and 9 by Piroxicam confer neuroprotection in cerebral ischemia: An in silico evaluation of the hypothesis
  25. Alleviation of glutamate mediated neuronal insult by piroxicam in rodent model of focal cerebral ischemia: a possible mechanism of GABA agonism
  26. Melatonin renders neuroprotection by protein kinase C mediated aquaporin-4 inhibition in animal model of focal cerebral ischemia
  27. Application of Mathematical Modelling as a Tool to Analyze the EEG Signals in Rat Model of Focal Cerebral Ischemia
  28. Rhamnetin Attenuates Oxidative Stress and Matrix Metalloproteinase in Animal Model of Ischemia/Reperfusion: A Possible Antioxidant Therapy in Stroke
  29. Aquaporin-4 Inhibition Mediates Piroxicam-Induced Neuroprotection against Focal Cerebral Ischemia/Reperfusion Injury in Rodents
  30. Does Piroxicam really protect ischemic neurons and influence neuronal firing in cerebral ischemia? An exploration towards therapeutics
  31. A Strategic Application of Fast Fourier Transform as a Novel Tool to Evaluate the Extent of Neuronal Insult in Rat Model of Focal Cerebral Ischemia
  32. Neuroprotection by μ-calpain and matrix metalloproteinases inhibition by Piroxicam in cerebral ischemia: an in silico study
  33. Neuroprotective effects of quercetin in chemical hypoxia: in silico evaluation of the hypothesis exploring PKC inhibition-mediated pharmacotherapy
  34. Aquaporin-4 in Cerebral Edema Following Ischemia/Reperfusion Injury: Exploration of Novel Therapeutic Strategies
  35. Combination therapy of Ifenprodil with Piroxicam may be an effective therapeutic intervention in cerebral stroke: A hypothesis
  36. Cognitive effects of NSAIDs in cerebral ischemia: A hypothesis exploring mechanical action mediated pharmacotherapy
  37. Neuroprotective potential of Piroxicam in cerebral ischemia: An in silico evaluation of the hypothesis to explore its therapeutic efficacy by inhibition of aquaporin-4 and acid sensing ion channel1a
  38. Erratum to “An in silico strategy to explore neuroprotection by quercetin in cerebral ischemia: A novel hypothesis based on inhibition of matrix metalloproteinase (MMPs) and acid sensing ion channel 1a (ASIC1a)” [Med. Hypotheses 79 (1) (2012) 76–81]
  39. An in-silico strategy to explore neuroprotection by quercetin in cerebral ischemia: A novel hypothesis based on inhibition of matrix metalloproteinase (MMPs) and acid sensing ion channel 1a (ASIC1a)
  40. Minocycline and magnesium in combination may be a good therapeutic intervention for cerebral ischemia